Cargando…

The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review

INTRODUCTION: In patients affected by epithelial ovarian cancer (EOC) complete cytoreduction (CC) has been associated with higher survival outcomes. Artificial intelligence (AI) systems have proved clinical benefice in different areas of healthcare. OBJECTIVE: To systematically assemble and analyze...

Descripción completa

Detalles Bibliográficos
Autores principales: Parpinel, Giulia, Laudani, Maria Elena, Piovano, Elisa, Zola, Paolo, Lecuru, Fabrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972055/
https://www.ncbi.nlm.nih.gov/pubmed/36847148
http://dx.doi.org/10.1177/10732748231159553
_version_ 1784898239159336960
author Parpinel, Giulia
Laudani, Maria Elena
Piovano, Elisa
Zola, Paolo
Lecuru, Fabrice
author_facet Parpinel, Giulia
Laudani, Maria Elena
Piovano, Elisa
Zola, Paolo
Lecuru, Fabrice
author_sort Parpinel, Giulia
collection PubMed
description INTRODUCTION: In patients affected by epithelial ovarian cancer (EOC) complete cytoreduction (CC) has been associated with higher survival outcomes. Artificial intelligence (AI) systems have proved clinical benefice in different areas of healthcare. OBJECTIVE: To systematically assemble and analyze the available literature on the use of AI in patients affected by EOC to evaluate its applicability to predict CC compared to traditional statistics. MATERIAL AND METHODS: Data search was carried out through PubMed, Scopus, Ovid MEDLINE, Cochrane Library, EMBASE, international congresses and clinical trials. The main search terms were: Artificial Intelligence AND surgery/cytoreduction AND ovarian cancer. Two authors independently performed the search by October 2022 and evaluated the eligibility criteria. Studies were included when data about Artificial Intelligence and methodological data were detailed. RESULTS: A total of 1899 cases were analyzed. Survival data were reported in 2 articles: 92% of 5-years overall survival (OS) and 73% of 2-years OS. The median area under the curve (AUC) resulted 0,62. The model accuracy for surgical resection reported in two articles reported was 77,7% and 65,8% respectively while the median AUC was 0,81. On average 8 variables were inserted in the algorithms. The most used parameters were age and Ca125. DISCUSSION: AI revealed greater accuracy compared against the logistic regression models data. Survival predictive accuracy and AUC were lower for advanced ovarian cancers. One study analyzed the importance of factors predicting CC in recurrent epithelial ovarian cancer and disease free interval, retroperitoneal recurrence, residual disease at primary surgery and stage represented the main influencing factors. Surgical Complexity Scores resulted to be more useful in the algorithms than pre-operating imaging. CONCLUSION: AI showed better prognostic accuracy if compared to conventional algorithms. However further studies are needed to compare the impact of different AI methods and variables and to provide survival informations.
format Online
Article
Text
id pubmed-9972055
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-99720552023-03-01 The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review Parpinel, Giulia Laudani, Maria Elena Piovano, Elisa Zola, Paolo Lecuru, Fabrice Cancer Control An Inventory of Epithelial Ovarian Cancer Targets: “Evidence-based” Options-Review INTRODUCTION: In patients affected by epithelial ovarian cancer (EOC) complete cytoreduction (CC) has been associated with higher survival outcomes. Artificial intelligence (AI) systems have proved clinical benefice in different areas of healthcare. OBJECTIVE: To systematically assemble and analyze the available literature on the use of AI in patients affected by EOC to evaluate its applicability to predict CC compared to traditional statistics. MATERIAL AND METHODS: Data search was carried out through PubMed, Scopus, Ovid MEDLINE, Cochrane Library, EMBASE, international congresses and clinical trials. The main search terms were: Artificial Intelligence AND surgery/cytoreduction AND ovarian cancer. Two authors independently performed the search by October 2022 and evaluated the eligibility criteria. Studies were included when data about Artificial Intelligence and methodological data were detailed. RESULTS: A total of 1899 cases were analyzed. Survival data were reported in 2 articles: 92% of 5-years overall survival (OS) and 73% of 2-years OS. The median area under the curve (AUC) resulted 0,62. The model accuracy for surgical resection reported in two articles reported was 77,7% and 65,8% respectively while the median AUC was 0,81. On average 8 variables were inserted in the algorithms. The most used parameters were age and Ca125. DISCUSSION: AI revealed greater accuracy compared against the logistic regression models data. Survival predictive accuracy and AUC were lower for advanced ovarian cancers. One study analyzed the importance of factors predicting CC in recurrent epithelial ovarian cancer and disease free interval, retroperitoneal recurrence, residual disease at primary surgery and stage represented the main influencing factors. Surgical Complexity Scores resulted to be more useful in the algorithms than pre-operating imaging. CONCLUSION: AI showed better prognostic accuracy if compared to conventional algorithms. However further studies are needed to compare the impact of different AI methods and variables and to provide survival informations. SAGE Publications 2023-02-27 /pmc/articles/PMC9972055/ /pubmed/36847148 http://dx.doi.org/10.1177/10732748231159553 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle An Inventory of Epithelial Ovarian Cancer Targets: “Evidence-based” Options-Review
Parpinel, Giulia
Laudani, Maria Elena
Piovano, Elisa
Zola, Paolo
Lecuru, Fabrice
The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review
title The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review
title_full The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review
title_fullStr The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review
title_full_unstemmed The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review
title_short The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review
title_sort use of artificial intelligence for complete cytoreduction prediction in epithelial ovarian cancer: a narrative review
topic An Inventory of Epithelial Ovarian Cancer Targets: “Evidence-based” Options-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972055/
https://www.ncbi.nlm.nih.gov/pubmed/36847148
http://dx.doi.org/10.1177/10732748231159553
work_keys_str_mv AT parpinelgiulia theuseofartificialintelligenceforcompletecytoreductionpredictioninepithelialovariancanceranarrativereview
AT laudanimariaelena theuseofartificialintelligenceforcompletecytoreductionpredictioninepithelialovariancanceranarrativereview
AT piovanoelisa theuseofartificialintelligenceforcompletecytoreductionpredictioninepithelialovariancanceranarrativereview
AT zolapaolo theuseofartificialintelligenceforcompletecytoreductionpredictioninepithelialovariancanceranarrativereview
AT lecurufabrice theuseofartificialintelligenceforcompletecytoreductionpredictioninepithelialovariancanceranarrativereview
AT parpinelgiulia useofartificialintelligenceforcompletecytoreductionpredictioninepithelialovariancanceranarrativereview
AT laudanimariaelena useofartificialintelligenceforcompletecytoreductionpredictioninepithelialovariancanceranarrativereview
AT piovanoelisa useofartificialintelligenceforcompletecytoreductionpredictioninepithelialovariancanceranarrativereview
AT zolapaolo useofartificialintelligenceforcompletecytoreductionpredictioninepithelialovariancanceranarrativereview
AT lecurufabrice useofartificialintelligenceforcompletecytoreductionpredictioninepithelialovariancanceranarrativereview